GENFIT Stock Euronext Paris
Stocks
GNFT
FR0004163111
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - PTS | - |
|
| 07-03 | Genfit soars on news of U.S. reimbursement for a product |  |
| 07-03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
| Market Cap | 715M 0 825M 667M 613M 1.16B 78.69B 1.17B 7.85B 3.07B 39.23B 3.1B 3.03B 130B | P/E 2026 * |
36.9x | P/E 2027 * | 95x |
|---|---|---|---|---|---|
| Enterprise Value | 664M 0 766M 620M 569M 1.08B 73.07B 1.09B 7.29B 2.85B 36.42B 2.88B 2.81B 121B | EV / Sales 2026 * |
6.63x | EV / Sales 2027 * | 5.23x |
| Free-Float |
86.88% | Yield 2026 * |
-
| Yield 2027 * | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 16/09/2019 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 22/04/2021 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 27/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 16/06/2017 | |
| Director/Board Member | 54 | 15/09/1999 | |
| Director/Board Member | 58 | 16/06/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.68% | -0.54% | -2.73% | +13.55% | 48.22B | |
| +6.03% | +2.87% | +428.15% | +506.65% | 38.79B | |
| -2.21% | +7.03% | +25.08% | +5.51% | 38.41B | |
| +2.94% | -0.89% | +8.03% | +56.94% | 34.88B | |
| +1.98% | +3.97% | +13.89% | +40.90% | 29.19B | |
| +0.31% | -2.42% | +35.92% | +122.86% | 16B | |
| +0.47% | -3.48% | - | - | 16.05B | |
| +1.59% | +2.84% | +4.40% | +16.88% | 13.53B | |
| -0.98% | -7.07% | -5.76% | -37.52% | 12.22B | |
| Average | +1.05% | -0.61% | +63.37% | +90.72% | 27.48B | |
| Weighted average by Cap. | +1.21% | +0.21% | +80.81% | +109.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 100M 0 116M 93.45M 85.89M 162M 11.02B 164M 1.1B 430M 5.49B 434M 424M 18.22B | 124M 0 143M 116M 106M 201M 13.65B 203M 1.36B 533M 6.8B 537M 525M 22.56B |
| Net income | 22.88M 0 26.38M 21.34M 19.61M 37.1M 2.52B 37.44M 251M 98.22M 1.25B 99.06M 96.88M 4.16B | 6.8M 0 7.84M 6.34M 5.83M 11.03M 748M 11.13M 74.6M 29.19M 373M 29.44M 28.8M 1.24B |
| Net Debt | -51.12M -0 -58.93M -47.68M -43.82M -82.89M -5.62B -83.66M -561M -219M -2.8B -221M -216M -9.3B | -66.17M -0 -76.29M -61.72M -56.73M -107M -7.28B -108M -726M -284M -3.63B -287M -280M -12.04B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- GNFT Stock
- GNFT Stock
Select your edition
All financial news and data tailored to specific country editions
